Mónica Inês
Mónica Inês
Pfizer Portugal
Verified email at pfizer.com
Title
Cited by
Cited by
Year
Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy
T Coelho, M Inês, I Conceição, M Soares, M de Carvalho, J Costa
Neurology 91 (21), e1999-e2009, 2018
502018
Epidemiology of transthyretin familial amyloid polyneuropathy in Portugal: a nationwide study
M Ines, T Coelho, I Conceicao, F Duarte-Ramos, M de Carvalho, J Costa
Neuroepidemiology 51 (3-4), 177-182, 2018
252018
An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium, Spain, Portugal, and Italy
K Wilson, R Hettle, S Marbaix, SD Cerezo, M Ines, L Santoni, L Annemans, ...
European journal of preventive cardiology 19 (5), 1173-1183, 2012
152012
Autovigilância da doença e qualidade de vida dos doentes diabéticos: estudo observacional em farmácias comunitárias
Z Mendes, S Guedes, JP Guerreiro, M Inês, A Sousa, A Miranda
Revista portuguesa de saúde pública 34 (1), 11-19, 2016
142016
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for atrial fibrillation in PortugalCost-effectiveness of new oral anticoagulants in Portuguese atrial …
J Costa, F Fiorentino, D Caldeira, M Inês, CL Pereira, L Pinheiro, ...
Revista Portuguesa de Cardiologia (English Edition) 34 (12), 723-737, 2015
122015
A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal
LS Miguel, NS Miguel, M Inês
Cost Effectiveness and Resource Allocation 11 (1), 1-8, 2013
122013
Epidemiology of transthyretin familial amyloid polyneuropathy in Portugal
M Inês, T Coelho, I Conceição, F Duarte-Ramos, M de Carvalho, J Costa
Orphanet Journal of Rare Diseases 10 (1), 1-1, 2015
52015
Transthyretin familial amyloid polyneuropathy impact on health-related quality of life
M Inês, T Coelho, I Conceição, LN Ferreira, M Carvalho, J Costa
Value in Health 18 (7), A672-A672, 2015
52015
Quinze anos de avaliação económica de medicamentos em Portugal: uma revisão
M Inês, M Gouveia, C Mateus, LS Miguel, A Pinto, CG Pinto
Revista Portuguesa De Farmacoterapia 6 (3), 12-28, 2014
52014
Análise de custo-efetividade do apixabano vs. Enoxaparina na prevenção do tromboembolismo venoso após artroplastia eletiva da anca ou joelho
O Lourenço, F Batel-Marques, J Carrasco, M Inês
Rev Port Farmacoter 4, 248-258, 2012
52012
PMS43 Cost-Minimization Analysis of Collagenase Clostridium Histolyticum Compared with Fasciectomy in Patients with Dupuytren'S Contracture in Portugal
M Inês, NM Silverio, E Erdogan-Ciftci
Value in Health 14 (7), A310, 2011
52011
Análise Probabilística De Custo-Efectividade: Utilização do Eletriptano no tratamento das crises de enxaqueca em Portugal
JM Félix, MS Inês, CM Acosta
Acta Med Port 18 (1), 2005
52005
Societal costs and burden of hereditary transthyretin amyloidosis polyneuropathy
M Inês, T Coelho, I Conceição, F Landeiro, M de Carvalho, J Costa
Amyloid 27 (2), 89-96, 2020
42020
Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus “no vaccination” and versus vaccination with the 23-valent …
M Gouveia, G Jesus, M Inês, J Costa, M Borges
Human vaccines & immunotherapeutics 15 (4), 850-858, 2019
42019
Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study
M Inês, T Coelho, I Conceição, L Ferreira, M de Carvalho, J Costa
Orphanet journal of rare diseases 15 (1), 1-9, 2020
32020
Prevalence of transthyretin familial amyloid polyneuropathy in Portugal
M Ines, T Coelho, I Conceicao, F Duarte-Ramos, M Carvalho, J Costa
Value in Health 18 (7), A662, 2015
32015
PCN63 cost-effectiveness of Sunitinib in patients with advanced or metastatic pancreatic neuroendocrine tumors in Portugal
M Soares, M Inês, M Contente
Value in Health 14 (7), A445, 2011
32011
Temporal trends in transthyretin familial amyloid polyneuropathy survival over a century
T Coelho, M Inês, I Concieção, P Saramago, M de Carvalho, J Costa
Int J Clin Neurosci Ment Health 3, P130, 2016
22016
The Challenges of Health Technology Assessment in Portugal
P Laires, M Inês, M Gouveia, C Mateus, LS Miguel, CG Pinto
Revista Portuguesa de Farmacoterapia 8 (3), 24-34, 2016
22016
Custo‐efetividade dos novos anticoagulantes orais na fibrilhação auricular em Portugal
J Costa, F Fiorentino, D Caldeira, M Inês, CL Pereira, L Pinheiro, ...
Revista Portuguesa de Cardiologia 34 (12), 723-737, 2015
22015
The system can't perform the operation now. Try again later.
Articles 1–20